LIVE MARKET TRACKER :   BSE SENSEX   33455.79      |    NSE NIFTY 10322.25    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Equity & Shares  :  Glenmark gains on entering into exclusive agreement with Cyndea Pharma

Glenmark gains on entering into exclusive agreement with Cyndea Pharma (19-Jul-2017)

Glenmark Pharmaceuticals is currently trading at Rs. 697.35, up by 5.70 points or 0.82% from its previous closing of Rs. 691.65 on the BSE.

The scrip opened at Rs. 692.00 and has touched a high and low of Rs. 699.50 and Rs. 692.00 respectively. So far 3,985 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 993.00 on 01-Nov-2016 and a 52 week low of Rs. 600.00 on 29-May-2017.

Last one week high and low of the scrip stood at Rs. 699.50 and Rs. 677.00 respectively. The current market cap of the company is Rs. 19,638.00 crore.

The promoters holding in the company stood at 46.50%, while Institutions and Non-Institutions held 40.80% and 12.70% respectively.

Glenmark Pharmaceuticals has entered into a development, license, manufacture and commercial supply agreement with Cyndea Pharma S.L., granting exclusive rights to use their technology for developing generic, soft-gelatin capsule formulations of certain pharmaceutical products.

Under this agreement, Glenmark receives exclusive rights to the United States and Canada markets for these soft-gelatin formulations in exchange for sharing development costs and profits from future sales. In addition, the agreement provides for the companies to add further soft-gelatin product candidates for development and commercialization, as new branded, soft gelatin, capsule-based drug products become available in the marketplace.

Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has several molecules in various stages of clinical development and is primarily focused in the areas of oncology, dermatology and respiratory.



Top News Today
Tayo Rolls' workers file cases for payment of unpaid wages
(11-Dec-2017)

Tayo RollsTayo Rolls' workers have filed cases against the company for payment of their unpaid wages. The company has not been able to pay wages to its workmen due to paucity of funds. Tayo Rolls is a metal fabrication......click on news to read complete article.

Tata Motors to increase prices of Passenger Vehicles
(11-Dec-2017)

Tata Motors to increase prices of Passenger VehiclesTata Motors is planning to increase prices of its entire passenger vehicles range by up to Rs 25,000, starting January 2018. This increase in price is due to rising input costs. The introductory prices......click on news to read complete article.

Jet Airways to induct 25 narrow-body planes in next 3 years
(11-Dec-2017)

Jet Airways to induct 25 narrow-body planes in next 3 yearsJet Airways is planning to induct almost 25 narrow-body planes into its fleet over the next three years even as it is yet to take a call on the delivery schedule of the Boeing 787 planes. Jet Airways is......click on news to read complete article.

International Stock News
Asian markets trade higher in early deals on Monday
(11-Dec-2017)

Asian markets trade higher in early deals on MondayAsian equity benchmark indices are trading higher in the early deals on Monday, lifted by encouraging employment data from the US that took the Standard & Poor's 500 Index to its third straight......click on news to read complete article.

US markets end at record highs on upbeat jobs data
(09-Dec-2017)

US markets end at record highs on upbeat jobs dataThe US markets traded with traction and ended near record high levels on Friday, as traders reacted positively to the closely watched monthly jobs report. The continued advance by stocks came following......click on news to read complete article.

US markets closed higher; S&P snaps four-day losing streak
(08-Dec-2017)

US markets closed higher; S&P snaps four-day losing streakThe US markets closed higher on Thursday, with the S&P 500 snapping a four-session losing streak on the back of gains in the technology, industrials and materials sectors. Traders focused on continued......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.